Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.
30-50% of patients with depression have signs of inflammation, and some of those markers may help predict which medication they'll respond to. Andrew...
A new antidepressant is under development that could change the field even more than esketamine. And even if it doesn't, its novel effects on the mind...
A new antidepressant is under development that could change the field even more than esketamine. And even if it doesn't, its novel effects on the mind...
A new antidepressant is under development that could change the field even more than esketamine. And even if it doesn't, its novel effects on the mind...
A new antidepressant is under development that could change the field even more than esketamine. And even if it doesn't, its novel effects on the mind...